Singapore markets closed

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.66-0.14 (-2.06%)
At close: 04:00PM EDT
6.66 0.00 (0.00%)
After hours: 05:00PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-263,320
-250,219
-204,472
-129,377
Depreciation & amortisation
15,853
13,624
4,294
1,256
Stock-based compensation
71,497
62,201
33,261
15,732
Change in working capital
6,403
4,015
-336
110,808
Accounts payable
2,394
91
-278
1,709
Other working capital
-196,551
-191,753
-212,355
23,427
Other non-cash items
-10,448
4,624
11,991
42,573
Net cash provided by operating activities
-140,504
-126,249
-160,874
39,474
Cash flows from investing activities
Investments in property, plant and equipment
-56,047
-65,504
-51,481
-16,047
Purchases of investments
-
0
-43,448
-34,000
Sales/maturities of investments
493,045
617,396
686,322
238,456
Net cash used for investing activities
-284,372
-121,573
-273,516
-422,433
Cash flows from financing activities
Common stock issued
-
391,802
-
0
Common stock repurchased
-
0
-16,050
-185
Net cash used provided by (used for) financing activities
402,915
401,244
476,790
351,156
Net change in cash
-21,961
153,422
42,400
-31,803
Cash at beginning of period
244,836
140,872
98,472
130,275
Cash at end of period
222,875
294,294
140,872
98,472
Free cash flow
Operating cash flow
-140,504
-126,249
-160,874
39,474
Capital expenditure
-56,047
-65,504
-51,481
-16,047
Free cash flow
-196,551
-191,753
-212,355
23,427